background: Although millions of deaths are caused each year by combustion-derived nanoparticulate (CDNP) air pollution, little is known about the health consequences of airborne-engineered nanoparticles. Whether inhaled nanoparticles can translocate into the circulation remains of crucial importance in understanding the potential for adverse health effects. Using complementary clinical and experimental studies we address the possibility of particle translocation, and the fate of inhaled nanoparticles. methods: Clinical Studies. 14 male volunteers were exposed to gold nanoparticles (particle size 3.8 nm; 5.8±0.3x106 particles/cm3) by inhalation for 2 hours. Blood and urine samples were analyzed for the presence of gold using high-resolution inductively-coupled mass spectroscopy (HR-ICPMS). Animal Studies. Male ApoE-/-mice fed a "Western diet" received twice-weekly intra-tracheal instillations of 5 nm gold nanoparticles or vehicle for 5 weeks (total particle mass of ~1 mg). The aortic arch, thoracic aorta, liver biopsies and blood were analyzed for gold using HR-ICPMS. Tissue samples were visualized using histology and Raman microspectroscopy.
